(c) The presence of tumor-induced suppression in HNSCC patients, as evidenced by increased proportions of myeloid derived suppressor cells, tumor-derived microvesicles, and regulatory T cells at the tumor site and in the peripheral circulation may account for lack of immune responses to EGFR peptides [23]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.